





























mL/min/1.73m2for~3 months with or without kidney damage [42]. GFR reflects the flow rate of
Stage Description
Kidney damage with normal or increased


























As previously mentioned,there is very little consistency inthe results of the studies referenced,











5.1 Acute Myocardial Infarction
Total Male Female pvalue
1311 785(59.9) 526(40.1) NfA












ThrombolyticsGiven;n(%) 303(23.1) 206(26.2) 97(18.4)
TIme to Thrombolytics (median·; mins.) 47(27,84) 45(27,70) 70(26,150)










































Confusion;n(%) 242(24.2) 134(24.0) 108(24.4)
Coma;n(%) 128(12.8) 63(11.3) 65(14.7)
Incontinence;n(%) 111(11.1) 69(12.4) 42(10.0)
Arm Weakness; n(%) 664(66.4) 366(65.6) 298(67.4)
legWeakness;n(%) 654(65.4) 357(64.0) 297(67.2)
Ga;tAffected;n(%) 477(47.7) 266(47.7) 211 (47.7)
Cranial Nerve Paratysis; n(%) 514(51.4) 286(51.3) 228(51.6)
p~lu6represent(om~risonsbetweenrmles..ndfemilles
CT/MRI;n{%)




Time to Dietidan; median· (days)
5eenbySociaIWorker;n(%)








































Table 5.15 Clinical Characteristics of Patients who had CoronaryAngiography(Coronary
Revascularization)
pvalue








Table 5.16 Clinical Characteristics of Patients with Criticat CAD (CoronaryRevascularization)
Total Mate Female pvalue
927 674172.7) 253127.3) NtA
62.1 ± 10.3 61.2±10.0 64.S±l0.7 <0.001


















Table 5.17 Clinical Characteristics of Patients Recommended for CABG (Coronary Revascularization)
Total Male Female pvalue
285 228(80.0) 57(20.0) NfA
62.8±9.3 62.1±9.0 6S.6±10.0 0.01
137(48.1) 107(46.9) 30(52.6) 0.4
106(37.2) 81(35.5) 25(43.9) 0.2
71(24.9) 52(22.8) 19(33.3) 0.1
6(2.1) 4(1.8) 2(3.5) 0.4
















10 (4.0, 48.0J 10(6.0,73.3)
5.5(4.3,6.2) 5.1(3.9,6.2)
62.5(19.5,106.0164.0121.0,105.8) 0.5






~~~~:,,,7;:~::-.::';;;;;::,~=,~.~~.,~~,..228 (33.8) 57(22.5) 0.001

5.4CommunitAcuiredPneumonia
Total Male Female pvalue
1166(100) 656(56.3) 510(43.7) N/A



















513 (78.2) 419(82.2) 0.2
Dyspnea;n(%) 793(68.0) 447(68.1)
Cough; n (%) 882(75.6) 493(75.2)
Sputum Production; n (%) 628 (S3.9) 351(53.5)
Sputum Microbiology; n (%) 414(35.5) 235(35.8)
PositiveCulture;n(%) 81(6.9) 47(7.2)
PleuriticChestPain;n(%) 309(26.5) 159(24.2)
Pleural Fluid; n (%) 29(2.5) 15(2.8)
Maintain PO Intake; n (%) 783(67.2) 452(68.9)
Mechanical Ventilation; n (%) 24(2.1) 20(3.0)
Temperature<35·or2:40·;n(%) 22(1.9) 17(2.6)
Respiratory Rate; n (%) (2: 30/min.) 235(20.2) 129(19.7)
Pulse Rate; mean ±SD(permin.)
ChestX-Ray;n(%) 1137(97.5) 644 (98.2)
>1 lobe; n(%) 250(21.4) 156(23.8)
Was POJMeasured?; n (%) 583(50.0) 326(49.7)
POJ;mean±SD(mmHg)





Hemoglobin; mean ±SD (g/l)
WhiteBloodCeIlCount;mean±SD
Urea; mean tSD (mmol/l)
Creatinine;meantSD(llmol/l) 124.8 ± 104.7 138.4±117.9
BloodCulture;n(%) 572(49.1) 324(49.4)






P51 Class V; n(%) 149(12.8) 107(16.3)



























Appropriateness of Antibiotic Choice (IV or Oral)
Appropriate;n(%) 867(74.4) 512(78.0) 355(69.6)
Yes;n(%) 768(65.9) 453(69.1) 315(61.8)
With Extra Meds.;n(%) 99(8.5) 59(9.0) 40(7.8)
Inappropriate;n(%) 299(25.6) 144(22.0) 155(30.4)
MacrolideOnty;n(%) 61(5.2) 29(4.4) 32(6.3)
WrongDrug;n(%) 219(18.8) 101(15.4) 118(23.1)
No Meds. Ordered; n (%) 14(1.2) 9(1.4) 5(1.0)


















CAP-community Kquired pneurnoni.l; lOS-length of suy
·Medjjnshownwithl25".7S"~centiles
Total Male Female pvalue
339 211(62.2) 128(37.8) NfA








;::'~:'h::::::;;::;~:;~~~"7~::::~::~~:,::,:::,::,:, GN _",.,5"1",("24'·h2,,,),, 30 (23.4) 0.99
Gender (Female)
Age
History of Hypertension 2.78
HistoryofCHF 0.37
~:I~~~:::~;::=~H~=~~~:::':
Table 5.30 Heatth Care A~~~::~:~:R at Dialysis Start (CKO!
Modality
OptimaIChoice;n(%) 104(49.3) 51(39.8)
HDSessionsperWeek(:S3);n{%1 244(98.7) 152(98.0) 92(100.0)
HD Hours per Session (4 hrs.l;n (%1 184 (74.2) 125(80.6) 59(63.4)
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Table 27 Health Care Access: DaysAwaitingCA8GforPatientswithUrgent Priority (Coronary
Revascularization)









p values represent comparisons between males and females
CHF-congestiveheartfailure;eGFR-estimatedglomerularfiltrationrate
pvatues represent comparisons between males and females
CHF-congestive heart failure; eGFR-estimated glomerular fil trationrate
Gender {Femalel
Age
pvalues represent comparisons between males and females
CHF-congestive heart failure; eGFR-estimatedglomerutarfiltration rate
p\lalues represent comparisons between males and females
CHF-congesti\le heart failure; eGFR-estimated glomerular filtrationrate
Table 35 Health Care Intervention: Appropriateness of Antibiotic Choice 12000 Guidelines) (CAP)





